NASDAQ$WALD
Waldencast plc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
WALD Q2 2024 — extraction skipped
Waldencast plc filed Form 6-K (accession 0001840199-24-000085) for Q2 2024, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.
- Form 6-K filed; press release body not parseable here.
- Reason: no headline numerics found by parser nor by Financial Datasets fallback.
- Numerics rely on the Financial Datasets fallback.
Headline financials
Revenue & EPS history
Waldencast · Revenue · Quarterly
$63.3M
Revenue by segment
Waldencast · $65.4M total across 2 segments · Q1 2025
- Milk Makeup$36.2M—55.4%
- Obagi Medical$29.2M—44.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q2 2024
-3.4%
Avg return
Earnings day
-4.7%
Avg return
5 days after
-6.5%
Avg return
30 days after
8%
1 / 12 earnings
Positive
+3.2%
Q3 2022
Best reaction
-19.5%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2025 | -19.5% | -30.0% | -27.4% | |
| Q4 2024 | -3.3% | -4.7% | -20.7% | |
| Q2 2024 | -0.3% | +4.2% | +23.1% | |
| Q2 2023 | -0.3% | +4.2% | +23.1% | |
| Q4 2023 | -0.4% | -0.2% | -17.6% | |
| Q1 2024 | -0.3% | -1.2% | -25.1% | |
| Q4 2022 | -12.3% | -17.9% | -22.2% | |
| Q3 2023 | -0.1% | -0.5% | -14.4% | |
| Q3 2022 | +3.2% | +7.3% | +5.1% | |
| Q1 2023 | -7.7% | -17.5% | +0.1% | |
| Q4 2021 | -0.2% | -0.1% | -0.1% | |
| Q4 2020 | -0.1% | +0.0% | -1.8% | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro